Document Detail


Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cells.
MedLine Citation:
PMID:  18822454     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The aim of this study was to assess the impact of nevirapine on a cervix carcinoma cell line. METHODS: HeLa cells were cultured in Dulbecco's modified Eagle medium supplemented with 20% fetal bovine serum at 37 degrees C and humidified 10% CO(2) in air. Nevirapine was purified from commercially available Viramune (Boehringer-Ingelheim), diluted in dimethyl sulfoxide (DMSO, Sigma-Aldrich) in 350 microMu final concentration and added to cell cultures 5 h after seeding. The same DMSO volume (0.2% final concentration) was added to controls. RESULTS: We found that nevirapine treatment induces reversible growth arrest and produces morphological changes in treated cells. In contrast with previous reports the observed effects of nevirapine did not correlate with promotion of differentiation, but with induction of premature senescence. Premature senescence as a response to anti-tumour treatment is a common effect of the most anti-cancer chemotherapeutics. Nevirapine treated cells strongly accumulated SA-b-Gal activity and also expressed increased levels of p53 and p21 when analyzed via RT-PCR. In order to further explore the potent mechanisms of premature senescence induction we performed pChk2-Thr68 immunofluorescence analysis and found that nevirapine treated cells exhibited increased number of nuclear foci, indicating activated DNA damage response. CONCLUSION: We propose that at least in HeLa cell line nevirapine treatment exerts an effect far from the differentiation process, by introducing the cells into premature senescence. Based on these data, the effects of RT inhibitors should be further investigated since they may represent an additional agent against human cancer.
Authors:
Konstantinos Stefanidis; Dimitris Loutradis; Leandros-Vassilios Vassiliou; Vasiliki Anastasiadou; Erasmia Kiapekou; Vasilis Nikas; Giorgos Patris; Georgios Vlachos; Alexandros Rodolakis; Aris Antsaklis
Related Documents :
21414204 - Atf3, an htlv-1 bzip factor binding protein, promotes proliferation of adult t-cell leu...
17766184 - Telomeres and telomerase in leukaemia and lymphoma.
409574 - Properties of human erythrocyte hexokinase related to cell age.
11336694 - Short telomeres in yeast are highly recombinogenic.
16668994 - Effects of o(2) and co(2) concentration on the steady-state fluorescence yield of singl...
19492414 - Alterations in the temporal expression and function of cadherin-7 inhibit cell migratio...
Publication Detail:
Type:  Journal Article     Date:  2008-09-26
Journal Detail:
Title:  Gynecologic oncology     Volume:  111     ISSN:  1095-6859     ISO Abbreviation:  Gynecol. Oncol.     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-13     Completed Date:  2008-12-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0365304     Medline TA:  Gynecol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  344-9     Citation Subset:  IM    
Affiliation:
Laboratory of Stem Cells, Division of Reproductive Medicine, Alexandra Maternity Hospital-1st Department of Obstetrics and Gynecology, University of Athens - Medical School, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Aging / drug effects
Cell Differentiation / drug effects
Cell Growth Processes / drug effects
DNA Damage
Female
Hela Cells
Humans
Nevirapine / pharmacology*
Uterine Cervical Neoplasms / drug therapy*,  genetics,  pathology
Chemical
Reg. No./Substance:
129618-40-2/Nevirapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The newer the better? Comparison of the 1997 and 2001 partin tables for pathologic stage prediction ...
Next Document:  The effects of simulated stuttering and prolonged speech on the neural activation patterns of stutte...